Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Use of an Electronic Medical Record to Track Adherence to the Mediterranean Diet in a US Neurology Clinical Practice.

Rasmussen E, Fosnacht Morgan AM, Munson R, Ong A, Patel S, Yucus C, Pham A, Patel V, Frigerio R, Lai R, Hillman L, Tideman S, Wang C, Simon KC, Martínez-González MÁ, Maraganore DM.

Mayo Clin Proc Innov Qual Outcomes. 2018 Feb 1;2(1):49-59. doi: 10.1016/j.mayocpiqo.2017.12.003. eCollection 2018 Mar.

2.

Structured Clinical Documentation to Improve Quality and Support Practice-Based Research in Headache.

Meyers S, Claire Simon K, Bergman-Bock S, Campanella F, Marcus R, Mark A, Freedom T, Rubin S, Semenov I, Lai R, Hillman L, Tideman S, Pham A, Frigerio R, Maraganore DM.

Headache. 2018 Aug 1. doi: 10.1111/head.13348. [Epub ahead of print]

PMID:
30066412
3.

Investigating ioflupane I123 injection and single photon emission tomography as an imaging biomarker for long-term sequelae following mild traumatic brain injury.

Reams N, Anderson J, Perlman R, Li W, Walters S, Tideman S, Wang C, Simon K, Frigerio R, Maraganore DM.

Brain Inj. 2018;32(1):105-112. doi: 10.1080/02699052.2017.1388443. Epub 2017 Nov 13.

PMID:
29131690
4.

From Brain Disease to Brain Health: Primary Prevention of Alzheimer's Disease and Related Disorders in a Health System Using an Electronic Medical Record-Based Approach.

Fosnacht AM, Patel S, Yucus C, Pham A, Rasmussen E, Frigerio R, Walters S, Maraganore D.

J Prev Alzheimers Dis. 2017;4(3):157-164. doi: 10.14283/jpad.2017.3.

5.

Structured clinical documentation in the electronic medical record to improve quality and to support practice-based research in epilepsy.

Narayanan J, Dobrin S, Choi J, Rubin S, Pham A, Patel V, Frigerio R, Maurer D, Gupta P, Link L, Walters S, Wang C, Ji Y, Maraganore DM.

Epilepsia. 2017 Jan;58(1):68-76. doi: 10.1111/epi.13607. Epub 2016 Nov 19.

6.

Genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson's disease.

Biernacka JM, Chung SJ, Armasu SM, Anderson KS, Lill CM, Bertram L, Ahlskog JE, Brighina L, Frigerio R, Maraganore DM.

Parkinsonism Relat Disord. 2016 Nov;32:25-30. doi: 10.1016/j.parkreldis.2016.08.002. Epub 2016 Aug 3.

7.

Low dose verapamil as an adjunct therapy for medically refractory epilepsy - An open label pilot study.

Narayanan J, Frech R, Walters S, Patel V, Frigerio R, Maraganore DM.

Epilepsy Res. 2016 Oct;126:197-200. doi: 10.1016/j.eplepsyres.2016.07.004. Epub 2016 Aug 4.

PMID:
27513375
8.

Quality improvement and practice-based research in neurology using the electronic medical record.

Maraganore DM, Frigerio R, Kazmi N, Meyers SL, Sefa M, Walters SA, Silverstein JC.

Neurol Clin Pract. 2015 Oct;5(5):419-429.

9.

Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement.

Puschmann A, Brighina L, Markopoulou K, Aasly J, Chung SJ, Frigerio R, Hadjigeorgiou G, Kõks S, Krüger R, Siuda J, Wider C, Zesiewicz TA, Maraganore DM.

Parkinsonism Relat Disord. 2015 Jul;21(7):675-82. doi: 10.1016/j.parkreldis.2015.04.029. Epub 2015 May 1. Review.

PMID:
25952959
10.

Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?

Markopoulou K, Biernacka JM, Armasu SM, Anderson KJ, Ahlskog JE, Chase BA, Chung SJ, Cunningham JM, Farrer M, Frigerio R, Maraganore DM.

Parkinsonism Relat Disord. 2014 Jun;20(6):584-9; discussion 584. doi: 10.1016/j.parkreldis.2014.02.021. Epub 2014 Mar 5.

11.

Alpha-synuclein repeat variants and survival in Parkinson's disease.

Chung SJ, Biernacka JM, Armasu SM, Anderson K, Frigerio R, Aasly JO, Annesi G, Bentivoglio AR, Brighina L, Chartier-Harlin MC, Goldwurm S, Hadjigeorgiou G, Jasinska-Myga B, Jeon BS, Kim YJ, Krüger R, Lesage S, Markopoulou K, Mellick G, Morrison KE, Puschmann A, Tan EK, Crosiers D, Theuns J, Van Broeckhoven C, Wirdefeldt K, Wszolek ZK, Elbaz A, Maraganore DM; Genetic Epidemiology of Parkinson's Disease Consortium.

Mov Disord. 2014 Jul;29(8):1053-7. doi: 10.1002/mds.25841. Epub 2014 Feb 27.

12.

Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.

Chung SJ, Armasu SM, Anderson KJ, Biernacka JM, Lesnick TG, Rider DN, Cunningham JM, Ahlskog JE, Frigerio R, Maraganore DM.

Parkinsonism Relat Disord. 2013 Jun;19(6):595-9. doi: 10.1016/j.parkreldis.2013.02.008. Epub 2013 Mar 16.

13.

Genomic determinants of motor and cognitive outcomes in Parkinson's disease.

Chung SJ, Armasu SM, Biernacka JM, Anderson KJ, Lesnick TG, Rider DN, Cunningham JM, Eric Ahlskog J, Frigerio R, Maraganore DM.

Parkinsonism Relat Disord. 2012 Aug;18(7):881-6. doi: 10.1016/j.parkreldis.2012.04.025. Epub 2012 May 30.

14.

Translation initiator EIF4G1 mutations in familial Parkinson disease.

Chartier-Harlin MC, Dachsel JC, Vilariño-Güell C, Lincoln SJ, Leprêtre F, Hulihan MM, Kachergus J, Milnerwood AJ, Tapia L, Song MS, Le Rhun E, Mutez E, Larvor L, Duflot A, Vanbesien-Mailliot C, Kreisler A, Ross OA, Nishioka K, Soto-Ortolaza AI, Cobb SA, Melrose HL, Behrouz B, Keeling BH, Bacon JA, Hentati E, Williams L, Yanagiya A, Sonenberg N, Lockhart PJ, Zubair AC, Uitti RJ, Aasly JO, Krygowska-Wajs A, Opala G, Wszolek ZK, Frigerio R, Maraganore DM, Gosal D, Lynch T, Hutchinson M, Bentivoglio AR, Valente EM, Nichols WC, Pankratz N, Foroud T, Gibson RA, Hentati F, Dickson DW, Destée A, Farrer MJ.

Am J Hum Genet. 2011 Sep 9;89(3):398-406. doi: 10.1016/j.ajhg.2011.08.009.

15.

Reactions to the different pigments in tattoos: a report of two cases.

Cruz FA, Lage D, Frigério RM, Zaniboni MC, Arruda LH.

An Bras Dermatol. 2010 Sep-Oct;85(5):708-11.

16.

Neuropathology of non-motor features of Parkinson disease.

Dickson DW, Fujishiro H, Orr C, DelleDonne A, Josephs KA, Frigerio R, Burnett M, Parisi JE, Klos KJ, Ahlskog JE.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S1-5. doi: 10.1016/S1353-8020(09)70769-2. Review.

PMID:
20082965
17.

Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease.

Frigerio R, Fujishiro H, Maraganore DM, Klos KJ, DelleDonne A, Heckman MG, Crook JE, Josephs KA, Parisi JE, Boeve BF, Dickson DW, Ahlskog JE.

Arch Neurol. 2009 Sep;66(9):1114-9. doi: 10.1001/archneurol.2009.170.

18.

Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies?

Frigerio R, Fujishiro H, Ahn TB, Josephs KA, Maraganore DM, DelleDonne A, Parisi JE, Klos KJ, Boeve BF, Dickson DW, Ahlskog JE.

Neurobiol Aging. 2011 May;32(5):857-63. doi: 10.1016/j.neurobiolaging.2009.05.019. Epub 2009 Jun 26.

19.

Incidental Lewy body disease and preclinical Parkinson disease.

DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW.

Arch Neurol. 2008 Aug;65(8):1074-80. doi: 10.1001/archneur.65.8.1074.

PMID:
18695057
20.

Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy?

Fujishiro H, Ahn TB, Frigerio R, DelleDonne A, Josephs KA, Parisi JE, Eric Ahlskog J, Dickson DW.

Acta Neuropathol. 2008 Sep;116(3):269-75. doi: 10.1007/s00401-008-0398-7. Epub 2008 Jun 14.

21.

Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease.

Fujishiro H, Frigerio R, Burnett M, Klos KJ, Josephs KA, Delledonne A, Parisi JE, Ahlskog JE, Dickson DW.

Mov Disord. 2008 Jun 15;23(8):1085-92. doi: 10.1002/mds.21989.

PMID:
18442129
22.

Alpha-synuclein, pesticides, and Parkinson disease: a case-control study.

Brighina L, Frigerio R, Schneider NK, Lesnick TG, de Andrade M, Cunningham JM, Farrer MJ, Lincoln SJ, Checkoway H, Rocca WA, Maraganore DM.

Neurology. 2008 Apr 15;70(16 Pt 2):1461-9. doi: 10.1212/01.wnl.0000304049.31377.f2. Epub 2008 Mar 5.

PMID:
18322262
23.

Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.

Dickson DW, Fujishiro H, DelleDonne A, Menke J, Ahmed Z, Klos KJ, Josephs KA, Frigerio R, Burnett M, Parisi JE, Ahlskog JE.

Acta Neuropathol. 2008 Apr;115(4):437-44. doi: 10.1007/s00401-008-0345-7. Epub 2008 Feb 9.

PMID:
18264713
24.

Number of children and risk of Parkinson's disease.

Frigerio R, Breteler MM, de Lau LM, Sanft KR, Bower JH, Ahlskog JE, Grossardt BR; Mariza de Andrade, Maraganore DM, Rocca WA.

Mov Disord. 2007 Apr 15;22(5):632-9.

PMID:
17265462
25.

Chemical exposures and Parkinson's disease: a population-based case-control study.

Frigerio R, Sanft KR, Grossardt BR, Peterson BJ, Elbaz A, Bower JH, Ahlskog JE, de Andrade M, Maraganore DM, Rocca WA.

Mov Disord. 2006 Oct;21(10):1688-92.

PMID:
16773614
26.

[Health care in groups from the perspective of the elderly].

Garcia MA, Yagi GH, Souza CS, Odoni AP, Frigério RM, Merlin SS.

Rev Lat Am Enfermagem. 2006 Mar-Apr;14(2):175-82. Epub 2006 May 8. Portuguese.

27.

Education and occupations preceding Parkinson disease: a population-based case-control study.

Frigerio R, Elbaz A, Sanft KR, Peterson BJ, Bower JH, Ahlskog JE, Grossardt BR, de Andrade M, Maraganore DM, Rocca WA.

Neurology. 2005 Nov 22;65(10):1575-83.

PMID:
16301484
28.

Controversies in optic neuritis pain diagnosis.

Agostoni E, Frigerio R, Protti A.

Neurol Sci. 2005 May;26 Suppl 2:s75-8. Review.

PMID:
15926026
29.

Atypical facial pain: clinical considerations and differential diagnosis.

Agostoni E, Frigerio R, Santoro P.

Neurol Sci. 2005 May;26 Suppl 2:s71-4. Review.

PMID:
15926025
30.

Migrainous cerebral infarction: case reports.

Frigerio R, Santoro P, Ferrarese C, Agostoni E.

Neurol Sci. 2004 Oct;25 Suppl 3:S300-1.

PMID:
15549569
31.

Optic neuritis: diagnostic criteria application in clinical practice.

Protti A, Spreafico C, Frigerio R, Perego E, Santoro P, Ferrarese C, Agostoni E.

Neurol Sci. 2004 Oct;25 Suppl 3:S296-7.

PMID:
15549567
32.

Visual evoked potentials in migraine.

Spreafico C, Frigerio R, Santoro P, Ferrarese C, Agostoni E.

Neurol Sci. 2004 Oct;25 Suppl 3:S288-90.

PMID:
15549564
33.

MIDAS questionnaire in the emergency setting.

Aliprandi A, Frigerio R, Santoro P, Frigo M, Iurlaro S, Vaccaro M, Tremolizzo L, Beghi E, Ferrarese C, Agostoni E.

Neurol Sci. 2004 Oct;25 Suppl 3:S274-5.

PMID:
15549558
34.

Management of headache in emergency room.

Agostoni E, Santoro P, Frigerio R, Frigo M, Beghi E, Ferrarese C.

Neurol Sci. 2004 Oct;25 Suppl 3:S187-9.

PMID:
15549533
35.

An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy.

Frigerio R, Fabrizi GM, Ferrarini M, Cavallaro T, Brighina L, Santoro P, Agostoni E, Cavaletti G, Rizzuto N, Ferrarese C.

Amyloid. 2004 Jun;11(2):121-4.

PMID:
15478468
36.

Antiepileptic drugs in the treatment of chronic headaches.

Agostoni E, Frigerio R, Santoro P.

Neurol Sci. 2003 May;24 Suppl 2:S128-31. Review.

PMID:
12811611
37.

Molecular and biochemical data on some glucose-6-phosphate dehydrogenase variants from southern Sardinia.

Frigerio R, Sole G, Lovicu M, Passiu G.

Haematologica. 1994 Jul-Aug;79(4):319-21.

38.

Listeria monocytogenes serotypes in Italian meat products.

Comi G, Frigerio R, Cantoni C.

Lett Appl Microbiol. 1992 Oct;15(4):168-171. doi: 10.1111/j.1472-765X.1992.tb00754.x.

PMID:
29389036
39.

[Erythrocyte antioxidant enzymatic systems and serum beta-glucuronidase in subjects with favism. Preliminary results].

Frigerio R, Sole G, Olla N, Lovicu M, Pigheddu D, Sessini AP, Passiu G, Carcassi U.

Ann Ital Med Int. 1988 Apr-Jun;3(2):87-92. Italian. No abstract available.

PMID:
3152848
40.

Iron overload and lysosomal stability in beta (0)-thalassemia intermedia: N-acetyl-beta-D-glucosaminidase isoenzymatic pattern.

Frigerio R, Sole G, Olla N, Lovicu M, Mela Q, Cacace E, Passiu G, Pitzus F, Carcassi U.

Birth Defects Orig Artic Ser. 1988;23(5B):25-8. No abstract available.

PMID:
3390549
41.

The erythroenzymopathies. With particular reference to glucose-6-phosphate dehydrogenase deficiency and favism.

Carcassi U, Arese P, Frigerio R, Passiu G.

Ann Ital Med Int. 1988;3 Suppl 1:23-30. Review. No abstract available.

PMID:
3152863
42.

G-6-PD Cagliari II: a new G-6-PD variant.

Frigerio R, Sole G, Olla N, Lovicu M, Passiu G, Carcassi U.

Haematologica. 1987 May-Jun;72(3):241-3. No abstract available.

PMID:
3114091
43.

Virus infection in beta-thalassemia intermedia.

Mela QS, Cacace E, Ruggiero V, Frigerio R, Pitzus F, Carcassi U.

Birth Defects Orig Artic Ser. 1987;23(5A):557-64. No abstract available.

PMID:
3500745
44.

Genetic heterogeneity of beta zero-thalassemia intermedia in Southern Sardinia.

Cacace E, Frigerio R, Olla N, Sole G, Mela Q, Perpignano G, Carcassi U.

Haematologica. 1985 Mar-Apr;70(2):95-100. No abstract available.

PMID:
2408975
45.

Iron overload and lysosomal stability in beta zero-thalassaemia intermedia and trait: correlation between serum ferritin and serum N-acetyl-beta-D-glucosaminidase levels.

Frigerio R, Mela Q, Passiu G, Cacace E, La Nasa G, Perpignano G, Carcassi UE.

Scand J Haematol. 1984 Sep;33(3):252-5.

PMID:
6505627
46.

Safety of flurbiprofen in subjects with G-6-PD deficiency. In vivo and in vitro results.

Passiu G, Mela Q, Perpignano G, Frigerio R, Cacace E.

Int J Clin Pharmacol Res. 1984;4(2):137-9.

PMID:
6469439
47.

In vitro effects of pentoxifylline on hemoglobin affinity for oxygen and electrolytic equilibrium of human blood.

Ferraresi I, Bozzini F, Torta D, Frigerio R, Bernasconi C, Agostoni A.

Ric Clin Lab. 1983 Oct-Dec;13(4):459-65.

PMID:
6658304
48.

A superfusion method for the study of secretion activity of isolated cerebral and endocrine tissues.

Braga PC, Frigerio R, Weiss A, Cocchi D, Fraschini F.

J Pharmacol Methods. 1981 Jun;5(4):287-92.

PMID:
7311567

Supplemental Content

Loading ...
Support Center